Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

News
Paliperidone Palmitate May Delay First Major Treatment Failure in Recent-Onset Schizophrenia
09/26/2022
Major treatment failure occurred at a lower rate in patients with recent-onset schizophrenia or schizophreniform disorder treated with the long-acting injectable (LAI) antipsychotic paliperidone palmitate (PP) compared with oral...
Major treatment failure occurred at a lower rate in patients with recent-onset schizophrenia or schizophreniform disorder treated with the long-acting injectable (LAI) antipsychotic paliperidone palmitate (PP) compared with oral...
Major treatment failure occurred...
09/26/2022
Psych Congress Network

Advertisement

News
Adults With ADHD Twice as Likely to Get Heart Disease
09/22/2022
Researchers also found that younger adults and males are more susceptible than older adults and females.
Researchers also found that younger adults and males are more susceptible than older adults and females.
Researchers also found that...
09/22/2022
Psych Congress Network
News
Low-Dose Ketamine Shows Promise in Treatment of Rare Syndrome Among Children
09/21/2022
Low-dose ketamine was safe, well-tolerated, and effective in treating clinical symptoms in children diagnosed with ADNP syndrome, a rare neurodevelopmental disorder, in a study conducted by researchers at Mount Sinai’s Seaver Autism Center.
Low-dose ketamine was safe, well-tolerated, and effective in treating clinical symptoms in children diagnosed with ADNP syndrome, a rare neurodevelopmental disorder, in a study conducted by researchers at Mount Sinai’s Seaver Autism Center.
Low-dose ketamine was safe,...
09/21/2022
Psych Congress Network
News
Analysis Finds No Interindividual Differences in Anxiolytic Effects of Exercise
09/21/2022
The anxiety-easing effects of exercise do not appear to differ between individuals, according to study findings published online ahead of print in Psychiatry Research.
The anxiety-easing effects of exercise do not appear to differ between individuals, according to study findings published online ahead of print in Psychiatry Research.
The anxiety-easing effects of...
09/21/2022
Psych Congress Network

Advertisement

News
TBI, PTSD Not Linked With Biomarker-Defined Alzheimer Disease
09/20/2022
Traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) were associated with an increased prevalence of mild cognitive impairment but not Alzheimer disease biomarkers in a study of Vietnam veterans, according to a new study...
Traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) were associated with an increased prevalence of mild cognitive impairment but not Alzheimer disease biomarkers in a study of Vietnam veterans, according to a new study...
Traumatic brain injury (TBI) and...
09/20/2022
Psych Congress Network
News
Extended-Release Viloxazine and Caffeine Combined Together May Raise Insomnia Risk
09/20/2022
Caffeine use combined with extended-release viloxazine appeared to increase the likelihood of insomnia but no other caffeine-related adverse events in adults with ADHD, according to a poster presentation on September 18th at Psych Congress in...
Caffeine use combined with extended-release viloxazine appeared to increase the likelihood of insomnia but no other caffeine-related adverse events in adults with ADHD, according to a poster presentation on September 18th at Psych Congress in...
Caffeine use combined with...
09/20/2022
Psych Congress Network
News
Cariprazine Effective Against ADT-resistant MDD
09/20/2022
Cariprazine could be effective in treating patients with major depressive disorder and inadequate response to antidepressant treatment.
Cariprazine could be effective in treating patients with major depressive disorder and inadequate response to antidepressant treatment.
Cariprazine could be effective...
09/20/2022
Psych Congress Network

Advertisement

News
Top Executives Share Message of Unification and Urgency With Psych Congress Attendees
09/19/2022
CEO Alliance for Mental Health members presented a message of unification, urgency, and equity.
CEO Alliance for Mental Health members presented a message of unification, urgency, and equity.
CEO Alliance for Mental Health...
09/19/2022
Psych Congress Network
News
Lumateperone Improves Symptoms in Patients with Bipolar Depression
09/19/2022
In a phase 3 trial, lumateperone significantly improved depression in patients with bipolar I or II disorder.
In a phase 3 trial, lumateperone significantly improved depression in patients with bipolar I or II disorder.
In a phase 3 trial, lumateperone...
09/19/2022
Psych Congress Network
News
FDA Clears Neuromodulation System for Patients With MDD
09/19/2022
The US Food and Drug Administration has provided Magnus Medical Inc. 510(k) clearance for the SAINT Neuromodulation System for the treatment of MDD in adults who have not achieved adequate improvement from prior antidepressant medications in...
The US Food and Drug Administration has provided Magnus Medical Inc. 510(k) clearance for the SAINT Neuromodulation System for the treatment of MDD in adults who have not achieved adequate improvement from prior antidepressant medications in...
The US Food and Drug...
09/19/2022
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use